ClariVest Asset Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

ClariVest Asset Management’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-366	Closed	-$9K	–	836
2021 Q3	$9K	Hold	366	–	–	﹤0.01%	539
2021 Q2	$5K	Hold	366	–	–	﹤0.01%	566
2021 Q1	$4K	Hold	366	–	–	﹤0.01%	562
2020 Q4	$3K	Hold	366	–	–	﹤0.01%	614
2020 Q3	$3K	Hold	366	–	–	﹤0.01%	605
2020 Q2	$3K	Hold	366	–	–	﹤0.01%	676
2020 Q1	$4K	Buy	+366	New	+$4.38K	﹤0.01%	595

Other funds holding OPNT

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

ClariVest Asset Management's OPNT Position: Q4 2021 in Review

ClariVest Asset Management sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q4 2021, closing a stake of 366 shares — an estimated $9K sold.

ClariVest Asset Management first reported a position in OPNT in Q1 2020 and held it in 7 quarters. The position peaked at $9K in Q3 2021. 42 funds tracked by Wall St. Rank hold OPNT as of Q4 2021.

ClariVest Asset Management reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
ClariVest Asset Management sold 366 Opiant Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $9K.
ClariVest Asset Management first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 7 quarters.
ClariVest Asset Management's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $9K in Q3 2021.
42 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on ClariVest Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.